Maiorov Sergei A, Laryushkin Denis P, Kritskaya Kristina A, Zinchenko Valery P, Gaidin Sergei G, Kosenkov Artem M
Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", Institute of Cell Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Brain Sci. 2024 Jun 29;14(7):668. doi: 10.3390/brainsci14070668.
Gi-coupled receptors, particularly cannabinoid receptors (CBRs), are considered perspective targets for treating brain pathologies, including epilepsy. However, the precise mechanism of the anticonvulsant effect of the CBR agonists remains unknown. We have found that WIN 55,212-2 (a CBR agonist) suppresses the synchronous oscillations of the intracellular concentration of Ca ions (epileptiform activity) induced in the neurons of rat hippocampal neuron-glial cultures by bicuculline or NHCl. As we have demonstrated, the WIN 55,212-2 effect is mediated by CBR receptors. The agonist suppresses Ca inflow mediated by the voltage-gated calcium channels but does not alter the inflow mediated by NMDA, AMPA, and kainate receptors. We have also found that phospholipase C (PLC), protein kinase C (PKC), and G-protein-coupled inwardly rectifying K channels (GIRK channels) are involved in the molecular mechanism underlying the inhibitory action of CBR activation against epileptiform activity. Thus, our results demonstrate that the antiepileptic action of CBR agonists is mediated by different intracellular signaling cascades, including non-canonical PLC/PKC-associated pathways.
G蛋白偶联受体,尤其是大麻素受体(CBRs),被认为是治疗包括癫痫在内的脑部疾病的潜在靶点。然而,CBR激动剂抗惊厥作用的确切机制仍不清楚。我们发现WIN 55,212-2(一种CBR激动剂)可抑制荷包牡丹碱或氯化铵在大鼠海马神经元-神经胶质细胞培养物的神经元中诱导的细胞内钙离子浓度的同步振荡(癫痫样活动)。正如我们所证明的,WIN 55,212-2的作用是由CBR受体介导的。该激动剂抑制电压门控钙通道介导的钙内流,但不改变NMDA、AMPA和海人藻酸受体介导的内流。我们还发现磷脂酶C(PLC)、蛋白激酶C(PKC)和G蛋白偶联内向整流钾通道(GIRK通道)参与了CBR激活对癫痫样活动抑制作用的分子机制。因此,我们的结果表明,CBR激动剂的抗癫痫作用是由不同的细胞内信号级联介导的,包括非经典的PLC/PKC相关途径。